I joined the Human Toxicology Program at the University of Iowa in 2008.

During my undergraduate study, I developed a great interest in health related research.

Dissertation Title: Population Pharmacokinetics and Exposure Toxicity Analysis of Vatalanib in Patients with Myelodysplastic Syndromes

Advisor: Daryl J. Murry, Pharm.D.

Year of Graduation: 2013

Program: Ph.D.

Current Position: Director, Head of Pharmacometrics

Current Employer/Institution: Otsuka Pharmaceutical Companies (U.S.) 

Publications from Human Toxicology Program Research:

Xiaofeng Wang, Kouros Owzar, Pankaj Gupta, Richard A. Larson, Flora Mulkey, Antonius A. Miller, Lionel D. Lewis, David Hurd, Ravi Vij, Mark J. Ratain, Daryl J. Murry; Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome (MDS): CALGB 10105 (Alliance), J Clin Pharmacol. 2014 Nov;78(5):10005-13.

LinkedIn Page